JP2022505585A5 - - Google Patents
Info
- Publication number
- JP2022505585A5 JP2022505585A5 JP2021521976A JP2021521976A JP2022505585A5 JP 2022505585 A5 JP2022505585 A5 JP 2022505585A5 JP 2021521976 A JP2021521976 A JP 2021521976A JP 2021521976 A JP2021521976 A JP 2021521976A JP 2022505585 A5 JP2022505585 A5 JP 2022505585A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024102779A JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749463P | 2018-10-23 | 2018-10-23 | |
| US62/749,463 | 2018-10-23 | ||
| PCT/US2019/057679 WO2020086730A1 (en) | 2018-10-23 | 2019-10-23 | Alk2 antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102779A Division JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022505585A JP2022505585A (ja) | 2022-01-14 |
| JPWO2020086730A5 JPWO2020086730A5 (https=) | 2022-10-18 |
| JP2022505585A5 true JP2022505585A5 (https=) | 2022-10-18 |
| JP7512272B2 JP7512272B2 (ja) | 2024-07-08 |
Family
ID=70331231
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521976A Active JP7512272B2 (ja) | 2018-10-23 | 2019-10-23 | Ａｌｋ２抗体及びその使用方法 |
| JP2024102779A Pending JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102779A Pending JP2024114820A (ja) | 2018-10-23 | 2024-06-26 | Ａｌｋ２抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12331124B2 (https=) |
| EP (1) | EP3870613A4 (https=) |
| JP (2) | JP7512272B2 (https=) |
| KR (1) | KR102919834B1 (https=) |
| CN (2) | CN118955715A (https=) |
| AU (1) | AU2019364415A1 (https=) |
| BR (1) | BR112021007660A2 (https=) |
| CA (1) | CA3116900A1 (https=) |
| IL (1) | IL282424A (https=) |
| WO (1) | WO2020086730A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7504880B2 (ja) | 2018-10-26 | 2024-06-24 | ケロス セラピューティクス インコーポレイテッド | Ａｌｋ２阻害剤の結晶形 |
| CN114761013A (zh) | 2019-09-27 | 2022-07-15 | 迪斯克医药公司 | 治疗骨髓纤维化和相关病症的方法 |
| CN115362175A (zh) * | 2020-02-11 | 2022-11-18 | 瑞泽恩制药公司 | 抗acvr1抗体及其用途 |
| US12508262B2 (en) | 2020-04-30 | 2025-12-30 | Keros Therapeutics, Inc. | Methods of using ALK2 inhibitors |
| WO2021231798A1 (en) | 2020-05-13 | 2021-11-18 | Disc Medicine, Inc. | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| WO2022240948A1 (en) * | 2021-05-11 | 2022-11-17 | Keros Therapeutics, Inc. | Methods of using alk2 and alk3 antibodies |
| WO2023081212A1 (en) * | 2021-11-02 | 2023-05-11 | Keros Therapeutics, Inc. | Methods of using alk2 inhibitors |
| US20240150474A1 (en) * | 2022-10-27 | 2024-05-09 | Regeneron Pharmaceuticals, Inc. | Anti-acvri antibodies and their use in the treatment of trauma-induced heterotopic ossification |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008501781A (ja) * | 2004-06-09 | 2008-01-24 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | 細胞の選択的アポトーシスのための抗体 |
| MX2009002418A (es) | 2006-09-05 | 2009-04-23 | Medarex Inc | Anticuerpos para las proteinas morfogenicas oseas y receptores de estas y metodos para su uso. |
| CN102548617B (zh) | 2009-03-30 | 2017-11-07 | 阿塞勒隆制药公司 | Bmp‑alk3拮抗剂和促进骨生长的用途 |
| US20130089560A1 (en) | 2010-03-17 | 2013-04-11 | Oncomed Pharmaceuticals Inc | Bone morphogenetic protein receptor binding agents and methods of their use |
| WO2012065059A2 (en) | 2010-11-12 | 2012-05-18 | The General Hospital Corporation | Treatment of atherosclerosis with bmp-alk3 antagonists |
| WO2015152183A1 (ja) | 2014-03-31 | 2015-10-08 | 大日本住友製薬株式会社 | 進行性骨化性線維異形成症の予防剤及び治療剤 |
| US20160075772A1 (en) | 2014-09-12 | 2016-03-17 | Regeneron Pharmaceuticals, Inc. | Treatment of Fibrodysplasia Ossificans Progressiva |
| BR112017015661A2 (pt) * | 2015-01-30 | 2018-03-20 | Saitama Medical University | anticorpo anti-alk2 |
| US10620204B2 (en) * | 2015-03-26 | 2020-04-14 | Vanderbilt University | Antibody-mediated neutralization of Ebola viruses |
| US12428484B2 (en) | 2018-12-06 | 2025-09-30 | Alexion Pharmaceuticals, Inc. | Anti-ALK2 antibodies and uses thereof |
| CN115362175A (zh) | 2020-02-11 | 2022-11-18 | 瑞泽恩制药公司 | 抗acvr1抗体及其用途 |
| JP2023530316A (ja) | 2020-06-16 | 2023-07-14 | インサイト・コーポレイション | 貧血の治療のためのａｌｋ２阻害剤 |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| WO2022098821A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating lymphopenia |
| WO2022099166A1 (en) | 2020-11-09 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating cardiovascular-related disease |
| WO2022240948A1 (en) | 2021-05-11 | 2022-11-17 | Keros Therapeutics, Inc. | Methods of using alk2 and alk3 antibodies |
-
2019
- 2019-10-23 CN CN202411099364.XA patent/CN118955715A/zh active Pending
- 2019-10-23 EP EP19877108.1A patent/EP3870613A4/en active Pending
- 2019-10-23 BR BR112021007660-3A patent/BR112021007660A2/pt unknown
- 2019-10-23 JP JP2021521976A patent/JP7512272B2/ja active Active
- 2019-10-23 CN CN201980085459.7A patent/CN113366019B/zh active Active
- 2019-10-23 CA CA3116900A patent/CA3116900A1/en active Pending
- 2019-10-23 WO PCT/US2019/057679 patent/WO2020086730A1/en not_active Ceased
- 2019-10-23 KR KR1020217015329A patent/KR102919834B1/ko active Active
- 2019-10-23 AU AU2019364415A patent/AU2019364415A1/en active Pending
-
2021
- 2021-04-19 IL IL282424A patent/IL282424A/en unknown
- 2021-04-22 US US17/237,240 patent/US12331124B2/en active Active
-
2024
- 2024-06-26 JP JP2024102779A patent/JP2024114820A/ja active Pending
-
2025
- 2025-05-14 US US19/207,888 patent/US20250270333A1/en active Pending